Congressman Brett Guthrie | Official U.S. House headshot
Congressman Brett Guthrie | Official U.S. House headshot
Congressman Brett Guthrie's bill, the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Reauthorization Act of 2024, has successfully passed the United States Senate and is now awaiting the President's signature to become law. The bill aims to provide essential support for Alzheimer's patients and their families.
"Last night, I was honored to see my bill, the BOLD Act, pass the United States Senate and head to the President’s desk to be signed into law," stated Congressman Guthrie. He emphasized that Alzheimer's disease impacts individuals and families nationwide without discrimination. The legislation seeks to improve early detection and diagnosis while offering resources for more effective treatments. Additionally, it provides caregiver support resources aimed at enhancing life quality for both patients and their caregivers.
The original BOLD Infrastructure for Alzheimer’s Act was enacted in 2018 and signed by President Trump in 2019. It established a public health framework supporting prevention, treatment, and care for those with Alzheimer's and related neurological conditions.
The reauthorization act will continue building an Alzheimer's network by setting up Public Health Centers of Excellence dedicated to dementia-related diseases. It also involves awarding cooperative agreements to public health departments at various levels—state, local, tribal—to help them develop interventions targeting early detection, risk reduction, and unnecessary hospitalization prevention.
Furthermore, robust data analysis will be required through Cooperative Agreements with the Centers for Disease Control (CDC). This ensures timely dissemination of information on Alzheimer’s disease, cognitive decline, caregiving issues, and health disparities.
Guthrie expressed his commitment: "I am proud this bill is one step closer to getting signed into law, and I won’t stop my hard work in Congress fighting on behalf of Alzheimer’s Disease patients and their families until we have a cure for this tragic disease."
Alerts Sign-up